Novartis to use Google technology for eye care

by The Associated Press

Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.

Terms of the agreement between the companies were not detailed in a statement released Tuesday by Novartis.

The drugmaker said its Alcon eye care division will license Google technology and work with a team from Google to develop a lens that uses microchips and miniaturized electronics. Novartis is focused on developing a contact lens that can provide a continuous measurement of in by measuring tear fluid.

It also said the lens has the potential to help restore the eye's natural auto focus on near objects for patients with who can no longer read without glasses. Presbyopia is a condition where the eye loses its ability to focus.

"This is a key step for us to go beyond the confines of traditional disease management, starting with the eye," Novartis CEO Joseph Jimenez said in a statement.

Related Stories

Patent talk: Google sharpens contact lens vision

date Apr 16, 2014

(Phys.org) —A report from Patent Bolt brings us one step closer to what Google may have in mind in developing smart contact lenses. According to the discussion Google is interested in the concept of contact ...

Eli Lilly to buy part of Novartis for $5.4 bn

date Apr 22, 2014

US pharmaceutical giant Eli Lilly said Tuesday it has reached an agreement to acquire the animal health division of Novartis of Switzerland for $5.4 billion (3.9 billion euros).

Novartis tries to make UK hospitals use $1000 drug

date Apr 24, 2012

(AP) -- Drug maker Novartis says it is taking legal action in Britain to make hospitals use an eye drug that costs 700 pounds ($1,130) per shot instead of a cheaper one that costs 60 pounds ($97).

Recommended for you

FDA reviewing safety of Essure birth control implant

date Jun 25, 2015

Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.